Squarepoint’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$270K Sell
301,987
-22,362
-7% -$21.1K ﹤0.01% 3784
2025
Q4
$328K Buy
324,349
+135,826
+72% +$169K ﹤0.01% 3531
2025
Q3
$253K Buy
188,523
+42,489
+29% +$45.1K ﹤0.01% 3792
2025
Q2
$115K Buy
146,034
+92,521
+173% +$109K ﹤0.01% 4134
2025
Q1
$54.6K Buy
53,513
+41,884
+360% +$79K ﹤0.01% 4329
2024
Q4
$28.7K Sell
11,629
-578
-5% -$1.11K ﹤0.01% 4908
2024
Q3
$18.7K Sell
12,207
-12,865
-51% -$19.6K ﹤0.01% 4026
2024
Q2
$43.6K Buy
25,072
+8,207
+49% +$12K ﹤0.01% 3919
2024
Q1
$26K Buy
16,865
+5,213
+45% +$8.52K ﹤0.01% 3913
2023
Q4
$19K Buy
+11,652
New +$20K ﹤0.01% 3911
2020
Q4
Sell
-34,045
Closed -$145K 3071
2020
Q3
$145K Buy
+34,045
New +$157K ﹤0.01% 2201
2019
Q1
Sell
-7,100
Closed -$258K 2277
2018
Q4
$258K Sell
7,100
-300
-4% -$9.23K ﹤0.01% 1564
2018
Q3
$254K Buy
7,400
+300
+4% +$9.68K ﹤0.01% 1626
2018
Q2
$229K Buy
7,100
+100
+1% +$3.45K ﹤0.01% 1487
2018
Q1
$202K Buy
+7,000
New +$185K ﹤0.01% 1491

Other funds holding IFRX

Squarepoint's IFRX Position: Q1 2026 in Review

Squarepoint reduced its InflaRx (IFRX) stake by 6.9% in Q1 2026, selling an estimated $21.1K and leaving 301,987 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #3784.

Squarepoint first reported a position in IFRX in Q1 2018 and has held it in 15 quarters since. The position peaked at $328K in Q4 2025. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • Squarepoint held 301,987 shares of InflaRx worth $270K as of Q1 2026.
  • Squarepoint sold 22,362 InflaRx shares in Q1 2026, an estimated $21.1K.
  • InflaRx made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3784 holding.
  • Squarepoint first reported a position in InflaRx in Q1 2018 and has held it in 15 quarters since.
  • Squarepoint's InflaRx position peaked at $328K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.